Diclofenac SR fast or fed state study design [Design Issues]

posted by xtianbadillo – Mexico, 2018-03-09 19:31  – Posting: # 18518
Views: 3,066

» Hello, I need your advice please for diclofenac SR 75 mg:
» should study be conducted in fasting or fed state?

https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm188529.pdf

Active ingredient: Diclofenac Sodium
Form/Route: Extended Release Tablets/Oral
Recommended studies: 2 studies

1. Type of study: Fasting
Design: Single-dose, two-way, crossover in-vivo
Strength: 100 mg
Subjects: Healthy males and nonpregnant females, general population.
Additional Comments:
______________________________________________________________________________
2. Type of study: Fed
Design: Single-dose, two-way, crossover in-vivo
Strength: 100 mg
Subjects: Healthy males and nonpregnant females, general population.
Additional comments:
_______________________________

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,286 posts in 4,100 threads, 1,317 registered users;
online 20 (2 registered, 18 guests [including 12 identified bots]).

I try not to think with my gut.
If I’m serious about understanding the world,
thinking with anything besides my brain, as tempting as that might be,
is likely to get me into trouble.    Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5